Skip to main content

Security report for mgslabs.co.uk

Eurofins Scientific · Healthcare · United Kingdom

Medium risk. 2 critical or high findings in SSL/TLS and DNS health.

Security score

75/100

Risk levelMedium

0–100, higher is better. How it is calculated

Eurofins BioPharma Product Testing UK is a division of Eurofins Scientific, a global leader in laboratory testing services. The company specializes in analytical and microbiological testing for biopharmaceutical products, offering a comprehensive range of services including microbiology, chemistry, stability studies, specialist services, and disinfectant testing. Their market position is strong, supported by a large global network and recognized certifications such as ISO 14001. The website reflects a professional and well-structured digital presence, targeting pharmaceutical and medical device manufacturers with regulatory-compliant testing solutions. Technically, the site employs modern web technologies including jQuery, Google Tag Manager, and OneTrust for cookie consent, ensuring a good user experience and compliance with privacy regulations. Security posture is solid with HTTPS and reCAPTCHA usage, though explicit security headers could be improved. The absence of WHOIS data due to domain naming rules is a limitation but does not detract from the evident legitimacy and professionalism of the business. Overall, the site demonstrates a mature digital infrastructure aligned with industry standards and regulatory requirements.

Scanned

NIS2 and GDPR posture

GDPR outside view
83/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

2 findings rated critical or high. Fix these first.

  1. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1
  2. DNS health

    DNS sends visitors and email to the right servers. Misconfigured records can cause outages or let someone redirect your traffic.

    • High

      Domain Expires Soon

      Domain expires in 3 days

      What to do: Renew domain registration before expiration

Need hands-on remediation? Email guard@offseq.com

Keep watching mgslabs.co.uk

This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
59
Security headers
70
Email security
85
DNS health
55
Network security
100
GDPR outside view
83
Average
75

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Eurofins Scientific operates in the healthcare sector with a focus on biopharma product testing. Their business model is service-oriented, providing laboratory testing and analytical services to pharmaceutical and medical device companies. The company leverages its global network to maintain a competitive advantage and offers a broad portfolio of testing services that cater to regulatory and quality control needs. The website indicates strategic partnerships and subsidiaries, such as PSS Insourcing Solutions, enhancing their service delivery capabilities. The presence of client testimonials and accreditations supports strong trust and credibility in the market. Eurofins targets regulated industries requiring high-quality testing, positioning itself as a reliable partner for compliance and product safety.

Security posture

The website demonstrates a good security posture with mandatory HTTPS encryption and the implementation of cookie consent mechanisms compliant with GDPR. The use of Google reCAPTCHA on forms helps mitigate automated abuse. However, explicit security headers like Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options are not evident, representing an area for improvement. No vulnerabilities or exposed sensitive data were detected in the HTML content. The absence of a published security policy or incident response information suggests an opportunity to enhance transparency and preparedness. Overall, the security maturity is adequate for the business type but could benefit from additional hardening and documentation.

Recommendations

  1. Implement and enforce comprehensive HTTP security headers including Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options to enhance protection against common web attacks.
  2. Publish a clear security policy and incident response plan on the website to improve transparency and customer trust.
  3. Conduct regular audits of third-party scripts and libraries to ensure no vulnerable components are in use.
  4. Enhance accessibility features to meet WCAG standards, improving usability for all users.
  5. Consider providing direct contact information such as verified company emails and phone numbers to facilitate communication and support.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Eurofins Scientific
Description
Eurofins BioPharma Product Testing UK offers expert analytical and microbiological testing services including microbiology, chemistry, stability services, specialist services, and disinfectant testing.
Key services
Microbiology testing, Chemistry testing, Stability services, Specialist services, Disinfectant testing, Elemental impurities testing by ICP-MS
Content quality
excellent
Branding
consistent

Technology

Stack
jQuery 3.6.1, Google Tag Manager, Google Analytics, OneTrust Cookie Consent, Plyr video player, Swiper slider
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
80/100
Good practices seen
  • HTTPS enabled
  • Cookie consent banner implemented
  • No exposed sensitive data in HTML
  • Use of reCAPTCHA for forms

Analytics and tracking

Services
Google Analytics, Plausible Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
LinkedIn Insight Tag, Google Ads
Marketing tools
OneTrust Cookie Consent
Transparency
good

Site quality

Design
excellent
User experience
good
Content relevance
excellent
Navigation
good
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and professional design
  2. Strong focus on biopharma product testing services
  3. Comprehensive cookie and privacy policies with consent mechanisms
  4. Use of modern analytics and marketing tools
  5. No direct contact emails or phone numbers found on main page; contact via form
  6. WHOIS data unavailable due to domain naming rules error but website is legitimate
  7. No security policy or incident response information explicitly found
Technical notes

Notes

The website uses a modern technology stack with jQuery 3.6.1, Google Tag Manager, Google Analytics, OneTrust for cookie consent, Plyr for video playback, and Swiper for interactive sliders. The site is mobile-optimized with responsive design elements and includes SEO best practices such as meta tags and Open Graph data. Performance is moderate, with potential for optimization in loading speed and accessibility compliance. The absence of a detected CMS suggests a custom or proprietary platform. Hosting details are not explicit but the use of CDN-hosted scripts indicates a distributed content delivery approach. Overall, the technical infrastructure supports a professional and scalable web presence suitable for an enterprise-level service provider.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with mgslabs.co.uk. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review mgslabs.co.uk.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.